Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder. The agreement gives the Company the option to acquire all of Vensica at a fixed price if significant value creating milestones are achieved. Read More
MISGAV, Israel, July 19, 2016 /PRNewswire/ -- Vensica Medical, a portfolio company of Trendlines Medical, announced the completion of... read more
The Official Networking and Conference App – Facilitating Partnering at the Innovation In Medtech Dublin 2016 event. This medical device... read more
Israeli startup Vensica is developing a needle-free, painless procedure for the delivery of Botox to treat overactive bladder. Israeli overactive... read more
Avner Geva, CEO of Vensica Medical, was interviewed on the current market pain of OAB (Overactive Bladder Syndrome) and... read more
Vensica Medical, an Israeli startup is treating overactive bladder with a range of innovations. Read More read more
© Copyright 2015. All Rights Reserved. 
Leave a Reply